Southern Symposium


Cork 2015

Professor Michael Goggins

Professor of Pathology, Medicine and Oncology, Director of Pancreatic Cancer Early Detection Laboratory, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA

Dr. Goggins is a Professor of Pathology, Medicine and Oncology at The Johns Hopkins University School of Medicine. He was born in New York City and moved to the West of Ireland as a teenager. He received his Bachelor’s degree and medical degree from Trinity College Dublin in 1988 and completed his internship and internal medicine training (1988-91) and gastroenterology and internal medicine fellowship training (1991-5) in St. James Hospital, Dublin. He was a lecturer in Clinical Medicine at Trinity from 1992-5. He then completed a research fellowship in Pathology and a clinical fellowship in gastroenterology at Johns Hopkins University and joined the faculty in 1999. He was promoted to Professor of Pathology, Medicine and Oncology in 2008. He has directed the Pancreatic Cancer Early Detection Research Laboratory since 1999. He is also an Attending Physician at Johns Hopkins Hospital in the Department of Medicine, the Division of Gastroenterology/Hepatology and member of the Division of Gastrointestinal Pathology and the Oncology Cancer. Dr. Goggins has written or co-authored more than 250 peer-reviewed publications. He was recognized a few years ago by Essential Science Indicators as the 6th-most highly cited pancreatic cancer scientist over the previous decade. He is a member of the Scientific Advisory Board of the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins University. He has served on numerous national advisory committees on pancreatic cancer. He has been a National Institute of Health grant reviewer for over 10 years and serves on the NCI Cancer Oncology Trials and Specialized Programs in Research Excellence (SPORE) study sections. He is a member of the GISPORE, and the PACGENE and Panc4 consortia. The goals of these studies include to identify new genes and markers of pancreatic cancer susceptibility and diagnosis. As a member of the pancreatic cancer research team at Johns Hopkins University, he was awarded the 2012 AACR Team Science award. He is PI of a Research Acceleration Award from the Pancreatic Cancer Action Network to fund a multicenter study (Cancer of the Pancreas Screening-5, CAPS5). His early detection research focuses on evaluating the potential clinical utility of measuring markers of early pancreatic cancer in pancreatic fluids and blood. The ongoing CAPS5 study is measuring mutations in the pancreatic fluid of patients undergoing pancreatic screening using next-generation sequencing.

View Webcast: 4th PROFESSOR GERRY O’SULLIVAN MEMORIAL LECTURE Genetics of Pancreatic Cancer and its Implications

Back to Guest Speakers...